A clinical trial to study the effects of a herbal drug Qurs Mufasil in patients with joint pain (Arthritis)
Phase 2
Completed
- Registration Number
- CTRI/2009/091/000746
- Lead Sponsor
- Hamdard National Foundation,Asaf Ali Road, New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
1.Patients of 20-70 years of age fulfilling the criteria of American College of Rheumatology (ACR) for the diagnosis of Rheumatoid Arthritis, who had never received disease modifying anti/Rheumatoid Drugs (DMARDs).
2.Presence of active disease as defined by the presence of >, 6 tender joints and >; 6 swollen joints.
Exclusion Criteria
1.Patients with concomitant renal/ hepatic insufficiently or sever gastrointestinal insufficiency.
2.Pregnant or lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in Swollen Joint Count,Tender Joint Count, Intensity of Pain-VAS (0-100), Morning Stiffness and ESRTimepoint: 4,8,12 weeks
- Secondary Outcome Measures
Name Time Method 1.ACR20 Response <br/ ><br>2.Improvement in quality of life as assessed by HAQ disability scoreTimepoint: 3 months